QURE uniQure NV

  1. Stocks
  2. Healthcare
  3. NASDAQ: QURE

Price (delayed)

$20.13

Market cap

$945.76M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.71

Enterprise value

$860.64M

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline ...

Highlights
The gross margin is up by 2.8% since the previous quarter
The company's revenue has shrunk by 80% YoY but it has surged by 73% QoQ
The gross profit has plunged by 79% YoY but it has soared by 78% from the previous quarter
The company's EPS has shrunk by 138% YoY
The net income has dropped by 138% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: AMGN SGMO BLUE RNA

Key stats

What are the main financial stats of QURE
Market
Shares outstanding
46.98M
Market cap
$945.76M
Enterprise value
$860.64M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.98
Price to sales (P/S)
8.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.08
Earnings
Revenue
$106.48M
EBIT
-$116.56M
EBITDA
-$108.02M
Free cash flow
-$162.75M
Per share
EPS
-$2.71
Free cash flow per share
-$3.48
Book value per share
$10.17
Revenue per share
$2.28
TBVPS
$13.28
Balance sheet
Total assets
$704.96M
Total liabilities
$228.96M
Debt
$142.89M
Equity
$476.01M
Working capital
$400.86M
Liquidity
Debt to equity
0.3
Current ratio
6.28
Quick ratio
6
Net debt/EBITDA
0.79
Margins
EBITDA margin
-101.4%
Gross margin
96.9%
Net margin
-119.1%
Operating margin
-141.2%
Efficiency
Return on assets
-18.1%
Return on equity
-26.3%
Return on invested capital
-42.4%
Return on capital employed
-18.5%
Return on sales
-109.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

QURE stock price

How has the uniQure stock price performed over time
Intraday
0.95%
1 week
4.3%
1 month
-4.14%
1 year
20.11%
YTD
-11.2%
QTD
-11.2%

Financial performance

How have uniQure's revenue and profit performed over time
Revenue
$106.48M
Gross profit
$103.14M
Operating income
-$150.33M
Net income
-$126.79M
Gross margin
96.9%
Net margin
-119.1%
QURE's operating income has shrunk by 150% YoY but it is up by 14% QoQ
The net income has dropped by 138% year-on-year
The company's revenue has shrunk by 80% YoY but it has surged by 73% QoQ
The gross profit has plunged by 79% YoY but it has soared by 78% from the previous quarter

Growth

What is uniQure's growth rate over time

Valuation

What is uniQure stock price valuation
P/E
N/A
P/B
1.98
P/S
8.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.08
The company's EPS has shrunk by 138% YoY
QURE's P/B is 69% below its 5-year quarterly average of 6.3 but 4.2% above its last 4 quarters average of 1.9
The equity is down by 20% YoY but it is up by 13% QoQ
The P/S is 94% lower than the 5-year quarterly average of 137.3 and 12% lower than the last 4 quarters average of 10.0
The company's revenue has shrunk by 80% YoY but it has surged by 73% QoQ

Efficiency

How efficient is uniQure business performance
The return on equity has dropped by 141% year-on-year and by 7% since the previous quarter
The ROA has plunged by 137% YoY and by 4.6% from the previous quarter
The return on invested capital has dropped by 124% year-on-year but it has increased by 18% since the previous quarter
The company's return on sales rose by 42% QoQ

Dividends

What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QURE.

Financial health

How did uniQure financials performed over time
The quick ratio has dropped by 64% year-on-year and by 14% since the previous quarter
The current ratio has plunged by 63% YoY and by 13% from the previous quarter
The debt is 70% lower than the equity
The debt to equity is up by 30% YoY but it is down by 9% from the previous quarter
The equity is down by 20% YoY but it is up by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.